Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes
Tereza Bartošová, Jiří Klempíř, Hana Hansíková, Reto Asmis · 2023
Read Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes by Tereza Bartošová, Jiří Klempíř, Hana Hansíková, Reto Asmis (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10740444.txt.
Description
Tereza Bartošová and co-authors test a blood marker for look-alike brain diseases in a 2023 study. Multiple system atrophy mimics Parkinson's disease and a related palsy in its early years, and no easy marker splits them. Low levels of coenzyme Q10 had been seen in the atrophy disease's tissues.
The team gauged the compound in plasma and in white blood cells across patient groups and controls. Cell levels ran clearly lower in the atrophy group than in Parkinson's patients or controls. The drop deepened as clinical involvement grew. Plasma told no such story. Cell levels of the compound may serve as a handy progression marker.
Catalog record
| CREATOR | Tereza Bartošová, Jiří Klempíř, Hana Hansíková, Reto Asmis |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |